Cargando…
Application of Artificial Intelligence Modeling Technology Based on Fluid Biopsy to Diagnose Alzheimer’s Disease
Background: There are no obvious clinical signs and symptoms in the early stages of Alzheimer’s disease (AD), and most patients usually have mild cognitive impairment (MCI) before diagnosis. Therefore, early diagnosis of AD is very critical. This paper mainly discusses the blood biomarkers of AD pat...
Autores principales: | Sh, Yuan, Liu, Benliang, Zhang, Jianhu, Zhou, Ying, Hu, Zhiyuan, Zhang, Xiuli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679840/ https://www.ncbi.nlm.nih.gov/pubmed/34924996 http://dx.doi.org/10.3389/fnagi.2021.768229 |
Ejemplares similares
-
Should artificial intelligence be used in conjunction with Neuroimaging in the diagnosis of Alzheimer’s disease?
por: Mirkin, Sophia, et al.
Publicado: (2023) -
An eXplainability Artificial Intelligence approach to brain connectivity in Alzheimer's disease
por: Amoroso, Nicola, et al.
Publicado: (2023) -
Diagnostic AI Modeling and Pseudo Time Series Profiling of AD and PD Based on Individualized Serum Proteome Data
por: Zhang, Jianhu, et al.
Publicado: (2021) -
Radiomic Features of the Hippocampus for Diagnosing Early-Onset and Late-Onset Alzheimer’s Disease
por: Du, Yang, et al.
Publicado: (2022) -
Early increase of cerebrospinal fluid 14-3-3ζ protein in the alzheimer's disease continuum
por: Lu, Yuanyuan
Publicado: (2022)